Algorithm for selecting therapy for vascular cognitive impairment

The article tells about current approaches to diagnosis and treatment of vascular cognitive impairment. The focus is on the administration of neurometabolic medicines.

Bibliographic Details
Published in:	Медицинский совет
Main Authors:	I. S. Preobrazhenskaya, D. O. Gromova
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2014-12-01
Subjects:	сосудистые когнитивные расстройства нейрометаболтеские препараты актовегин vascular cognitive impairment neurometabolic medicines actovegin
Online Access:	https://www.med-sovet.pro/jour/article/view/653

Similar Items

Cognitive impairment in arterial hypertension
by: N. V. Vakhnina
Published: (2015-12-01)

Chronic vascular disease of the brain (dyscirculatory encephalopathies)
by: N. V. Shakhparonova, et al.
Published: (2013-12-01)

Prediction for vascular mild cognitive impairment using the p300 event-related potentials technique
by: Yu. V. Sturova, et al.
Published: (2014-10-01)

Chronic cervicitis and chronic endometritis: general aspects of pathogenesis and pathogenetic therapy
by: A. L. Unanian, et al.
Published: (2013-12-01)

Diagnosis and treatment of post-stroke cognitive impairment
by: I. S. Preobrazhenskaya
Published: (2014-12-01)

Vascular and neurodegenerative cognitive impairments: a clinical case report
by: V. V. Zakharov, et al.
Published: (2016-07-01)

The clinical, diagnostic and therapeutic aspects of amnestic mild cognitive impairment
by: N. N. Koberskaya
Published: (2015-12-01)

Cognitive profile of patients with depressive disorders and its significance for antidepressant therapy and social functioning
by: K. E. Emelin, et al.
Published: (2018-07-01)

Изменения тета- и альфа-активности у пациентов с сосудистым когнитивным расстройством, прошедших когнитивную реабилитацию после коронарного шунтирования
by: Ирина Валерьевна Тарасова, et al.
Published: (2024-12-01)

Modern aspects of diagnosis and treatment of chronic cerebral ischemia. Application of naftidrofuryl
by: V. A. Parfyonov
Published: (2015-12-01)

Advances in neurometabolic therapy
by: V. V. Zakharov, et al.
Published: (2019-11-01)

TREATMENT OF COGNITIVE IMPAIRMENT AFTER STROKE
by: V. V. Zakharov, et al.
Published: (2018-02-01)

Cognitive impairment in arterial hypertension
by: M. V. Nesterova
Published: (2015-12-01)

Multimodal approach to treatment of neurological complications of chronic brain ischemia
by: M M Tanashyan, et al.
Published: (2018-12-01)

Diabetic polyneuropathy: effectiveness of therapy with Actovegin
by: O. A. Shavlovskaya
Published: (2014-12-01)

Diabetic polyneuropathy: efficacy of Actovegin
by: I. A. Strokov, et al.
Published: (2013-12-01)

CONTEMPORARY APPROACH TO THE CORRECTION OF COGNITIVE DISORDERS IN PATIENTS WITH VASCULAR COMORBIDITY
by: S. A. Rumianceva, et al.
Published: (2015-09-01)

Poststroke cognitive impairment
by: V. A. Parfenov
Published: (2019-12-01)

Diagnosis and treatment of cognitive impairment after stroke
by: V. V. Zakharov, et al.
Published: (2015-12-01)

ФИТОТЕРАПИЯ В РЕАБИЛИТАЦИИ ЛЕГКИХ И УМЕРЕННЫХ КОГНИТИВНЫХ РАССТРОЙСТВ
by: С. С. Василевский, et al.
Published: (2023-06-01)

FEATURES OF PIRIBEDIL USE IN THE TREATMENT OF MILD COGNITIVE IMPAIRMENTS IN PATIENTS WITH CHRONIC HEART FAILURE
by: N. S. Akimova, et al.
Published: (2015-09-01)

TREATMENT OF COMPLICATED FORMS OF CHRONIC VENOUS INSUFFICIENCY
by: I. G. Uchkin, et al.
Published: (2017-06-01)

КОГНИТИВНЫЕ НАРУШЕНИЯ ПРИ САХАРНОМ ДИАБЕТЕ У ЛИЦ ПОЖИЛОГО ВОЗРАСТА
by: А. А. Фирсов, et al.
Published: (2014-08-01)

Vascular cognitive impairment. Use of naftidrofuryl
by: E. Y. Suslova, et al.
Published: (2014-12-01)

Experience of actovegin use in a patient with cognitive impairment in diabetes mellitus (clinical case)
by: M. V. Ovsyuk
Published: (2020-06-01)

Cognitive functionбpsychoemotional disorders and quality of life in patients with acute ischemic stroke
by: O. E. Malneva, et al.
Published: (2018-07-01)

Pantogam activ (D-, L-hopantenic acid) in the treatment of cognitive and anxiety disorders in patients with arterial hypertension
by: A. B. Smulevich, et al.
Published: (2018-07-01)

Determination of neurometabolism in patients with mild and moderate cognitive impairments
by: N. N. Mikheev, et al.
Published: (2016-02-01)

Faktory sosudistogo riska, kognitivnyerasstroystva i izmeneniya kartiny MRT golovnogomozga u bol'nykh sakharnym diabetom 2 tipa
by: Lyudmila Alexandrovna Chugunova, et al.
Published: (2006-12-01)

Cognitive impairment in patients with bone marrow transplantation (review)
by: S. Yu. Fedorova, et al.
Published: (2018-07-01)

Diagnosis and treatment of chronic cerebral ischemia (clinical discussion)
by: V. V. Zakharov, et al.
Published: (2018-11-01)

Occipital lobe lesions: some clinical, pathogenic and therapeutic features
by: I. V. Damulin
Published: (2016-12-01)

Vascular cognitive impairment
by: N.V. Vakhnina
Published: (2014-05-01)

Vascular cognitive impairment: issues of diagnosis and treatment
by: A. B. Lokshina, et al.
Published: (2023-05-01)

Actovegin in the treatment of patients with cognitive impairments in the chronic cerebral ischemia
by: L. M. Boriskina
Published: (2015-12-01)

Sleep disorders and their significance in the development of cognitive impairments
by: Irina Sergeyevna Preobrazhenskaya
Published: (2013-12-01)

Criteria for diagnosis and classification of vascular cognitive impairment
by: A. Y. Emelin, et al.
Published: (2022-12-01)

Cognitive impairment in arterial hypertension
by: N. V. Pizova
Published: (2015-12-01)

С-РЕАКТИВНЫЙ БЕЛОК КАК МАРКЕР СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ, ЗЛОКАЧЕСТВЕННЫХ НОВООБРАЗОВАНИЙ И ПСИХИЧЕСКИХ РАССТРОЙСТВ (ОБЗОР ЛИТЕРАТУРЫ)
by: О. Л. Никифорова, et al.
Published: (2023-03-01)

Vascular cognitive impairment – definition and terms
by: Denisa Pirscoveanu, et al.
Published: (2012-03-01)